Technology
Health
Pharmaceutical

VBI Vaccines

$0.7784
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0622 (-7.40%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell VBI Vaccines and other stocks, options, ETFs, and crypto commission-free!

About VBIV

VBI Vaccines, Inc. New Common Stock (Canada), also called VBI Vaccines, is a biopharmaceutical company. Read More It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA.

CEO
Employees
112
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
82.09M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
790.73K
High Today
$0.86
Low Today
$0.767
Open Price
$0.8405
Volume
472.94K
52 Week High
$2.90
52 Week Low
$0.575

Collections

Technology
Health
Pharmaceutical
Biopharmaceutical
2016 IPO
US
North America
Canada

VBIV Earnings

-$0.28
-$0.24
-$0.19
-$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 25, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.